FDA Inspection 717037 — Janssen Biotech Inc.

Janssen Biotech Inc. — FEI 3006473233

The FDA completed an inspection of Janssen Biotech Inc. on April 14, 2011 in Horsham, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 14, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Horsham, PA (United States)

Citations

IDCFRDescription
241921 CFR 211.198(a)Complaint Handling Procedure